Literature DB >> 16524580

Evaluation of CD34 antigen expression following tamoxifen as primary treatment for breast cancer.

B B da Silva1, E R de Carvalho Gonçalves Nunes Galvão, L G Dos Santos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16524580     DOI： 10.1016/j.ijgo.2006.01.001

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN： 0020-7292            Impact factor:   3.561


× No keyword cloud information.
  1 in total

1.  Effect of raloxifene on vascular endothelial growth factor expression in breast carcinomas of postmenopausal women.

Authors:  B B da Silva; A R dos Santos; C G Pires; P V Lopes-Costa
Journal:  Cell Prolif       Date:  2009-05-29       Impact factor: 6.831
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.